Sitagliptin Phosphate

CAS 654671-77-9 55 current records 3 historicalSmall Molecule

Who holds supplier records for Sitagliptin Phosphate? 55 organisations hold a current record for Sitagliptin Phosphate: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 33 of them hold a valid EU Certificate of Suitability (32 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (30), China (11), Spain (4), Netherlands (1) and 4 other countries (4); not recorded for 5.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Sitagliptin Phosphate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sitagliptin-phosphate

Reading the evidence

  • 55 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    30 of the 50 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 24 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (55)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Sitagliptin Phosphate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Sitagliptin Phosphate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (32)

Certificates of Suitability on the EDQM register for Sitagliptin Phosphate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 47 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HARMAN FINOCHEM LIMITED MumbaiIN
CEP 2021-117 - Rev 02
Sitagliptin phosphate monohydrate
Oct 2026—
HONOUR LAB LIMITED HyderabadIN
CEP 2016-324 - Rev 02
Sitagliptin phosphate monohydrate
Oct 2026—
DONGBANG FUTURE TECH & LIFE CO., LTD. Hwaseong-SiKR
CEP 2020-028 - Rev 04
Sitagliptin phosphate monohydrate
Sept 2026—
ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO. LTD. TaizhouCN
CEP 2025-261 - Rev 00
Sitagliptin phosphate monohydrate
Sept 2026—
CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED HyderabadIN
CEP 2025-281 - Rev 00
Sitagliptin phosphate monohydrate
Jul 2026—
ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. ShaoxingCN
CEP 2025-199 - Rev 00
Sitagliptin phosphate monohydrate
Jul 2026Inspected Mar 2025
Germany
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2024-525 - Rev 00
Sitagliptin phosphate monohydrate
Jun 2026—
LEE PHARMA LIMITED HyderabadIN
CEP 2022-042 - Rev 01
Sitagliptin phosphate monohydrate
Apr 2026—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2024-229 - Rev 02
Sitagliptin phosphate monohydrate, 1567
Apr 2026—
UNION QUIMICO FARMACEUTICA, S.A BarcelonaES
CEP 2017-252 - Rev 01
Sitagliptin phosphate monohydrate
Apr 2026—
AMOLI ORGANICS PRIVATE LIMITED MumbaiIN
CEP 2025-485 - Rev 00
Sitagliptin phosphate monohydrate, Process-II
Mar 2026—
MSN LIFE SCIENCES PRIVATE LIMITED KamareddyIN
CEP 2024-526 - Rev 00
Sitagliptin phosphate monohydrate
Mar 2026—
CHEMO SMS ENTERPRISE, SL MadridES
CEP 2025-049 - Rev 01
Sitagliptin phosphate monohydrate, Process-II
Mar 2026—
QUIMICA SINTETICA S.A. Alcala De HenaresES
CEP 2024-564 - Rev 00
Sitagliptin phosphate monohydrate
Feb 2026Inspected Apr 2025
Spain
BIOCON LIMITED BengaluruIN
CEP 2023-366 - Rev 01
Sitagliptin phosphate monohydrate, Process-II
Jan 2026—
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2020-037 - Rev 02
Sitagliptin phosphate monohydrate
Jan 2026—
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2021-175 - Rev 01
Sitagliptin phosphate monohydrate
Jan 2026—
WAVELENGTH ENTERPRISES LTD. Petah TikvaIL
CEP 2024-213 - Rev 00
Sitagliptin phosphate monohydrate
Dec 2025—
IOL CHEMICALS AND PHARMACEUTICALS LTD LudhianaIN
CEP 2024-063 - Rev 00
Sitagliptin phosphate monohydrate
Oct 2025—
MSN PHARMACHEM PRIVATE LIMITED Sangareddy DistrictIN
CEP 2016-262 - Rev 02
Sitagliptin phosphate monohydrate, Crystalline, micronised and non-micronised
Sept 2025—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2025-020 - Rev 00
Sitagliptin phosphate monohydrate, Product code: SPT-4
Sept 2025—
RUYUAN HEC PHARM CO., LTD. ShaoguanCN
CEP 2024-352 - Rev 01
Sitagliptin phosphate monohydrate, Enzymatic method
Aug 2025—
ZHEJIANG JINGSHENG PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2023-453 - Rev 01
Sitagliptin phosphate monohydrate, Process II
Aug 2025—
MICRO LABS LIMITED BengaluruIN
CEP 2025-087 - Rev 00
Sitagliptin phosphate monohydrate, Process-II
May 2025—
OPTIMUS DRUGS PRIVATE LIMITED HyderabadIN
CEP 2023-273 - Rev 00
Sitagliptin phosphate monohydrate
May 2025—
LAURUS LABS LIMITED HyderabadIN
CEP 2020-215 - Rev 02
Sitagliptin phosphate monohydrate
May 2025—
MOREPEN LABORATORIES LIMITED BaddiIN
CEP 2019-040 - Rev 01
Sitagliptin phosphate monohydrate
May 2025Inspected Mar 2026
Spain
AMI LIFESCIENCES PRIVATE LIMITED KarakhadiIN
CEP 2024-249 - Rev 00
Sitagliptin phosphate monohydrate, Process II
Dec 2024Inspected Oct 2025
Slovakia
HIKAL LIMITED BangaloreIN
CEP 2022-138 - Rev 00
Sitagliptin phosphate monohydrate
Oct 2024Inspected Nov 2025
Switzerland
TORRENT PHARMACEUTICALS LIMITED AhmedabadIN
CEP 2023-248 - Rev 00
Sitagliptin phosphate monohydrate
Apr 2024—
ALMELO PRIVATE LIMITED Shabashpally VillageIN
CEP 2022-214 - Rev 00
Sitagliptin phosphate monohydrate
Mar 2024—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
R0-CEP 2021-228 - Rev 00
Sitagliptin phosphate monohydrate
Jul 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Sitagliptin Phosphate are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • Viwit Pharmaceutical Co., Ltd.
    China · Inactive DMF 30181, 29226 · filed Dec 2015
  • SINTENOVO SA DE CV
    Inactive DMF 28908 · filed May 2015
  • Sichuan Xieli Pharmaceutical Co Ltd
    China · Inactive DMF 26495 · filed Sept 2012

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Sitagliptin Phosphate is an orally active inhibitor of the DPP-4 enzyme, which is involved in glucose metabolism, and is used in the treatment of type 2 diabetes mellitus. It helps to increase insulin production and decrease the amount of sugar made by the body.

Chemical identity

IUPAC name
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid;hydrate
Canonical SMILES
C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N.O.OP(=O)(O)O
InChIKey
GQPYTJVDPQTBQC-KLQYNRQASA-N
Synonyms
glactiv, janumet component sitagliptin phosphate, januvia, mk-0431, mk0431, ono-5435, sitagliptin monophosphate monohydrate, sitagliptin phosphate hydrate, sitagliptin phosphate monohydrate, stelujan component sitagliptin phosphate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Dipeptidyl Peptidase 4 Inhibitor
Mechanism of action
Dipeptidyl Peptidase 4 Inhibitors

Therapeutic areas

EndocrinologyMetabolic DiseasesDiabetology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Sitagliptin Phosphate?

55 organisations hold an active US FDA Type II Drug Master File or a CEP for Sitagliptin Phosphate: Biocon Limited (India), Dr. Reddy's Laboratories Ltd. (India), MSN LIFE SCIENCES PRIVATE LIMITED (India), ALIVUS LIFE SCIENCES LTD (India), AMI LIFESCIENCES PRIVATE LTD (India), HIKAL LTD (India), HONOUR LAB LTD (India) and LEE PHARMA LTD (India), and 47 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Sitagliptin Phosphate Drug Master Files are active?

Biocon Limited (DMF 33143, 34987), Dr. Reddy's Laboratories Ltd. (DMF 40524, 35580), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 39497, 34378), ALIVUS LIFE SCIENCES LTD (DMF 25773, 26783), AMI LIFESCIENCES PRIVATE LTD (DMF 39354, 37030), HIKAL LTD (DMF 34734, 31579), HONOUR LAB LTD (DMF 30857, 32968) and LEE PHARMA LTD (DMF 37299, 35198) and 40 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Sitagliptin Phosphate records mean?

3 organisations have only inactive Type II DMFs for Sitagliptin Phosphate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Sitagliptin Phosphate have a European Certificate of Suitability?

Yes. 33 organisations hold a valid CEP for Sitagliptin Phosphate on the EDQM register, including HARMAN FINOCHEM LIMITED Mumbai (IN), HONOUR LAB LIMITED Hyderabad (IN), DONGBANG FUTURE TECH & LIFE CO., LTD. Hwaseong-Si (KR), ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO. LTD. Taizhou (CN), CHIERON ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad (IN) and ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. Shaoxing (CN) and 26 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Sitagliptin Phosphate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Sitagliptin Phosphate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.